Oslo universitetssykehus, Radiumhospitalet ( Site 4501)

Oslo 0379

1 studies enrolling now · 1 studies all time

What they study most

Esophageal Squamous Cell Carcinoma

Studies at this site

• A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B) — Recruiting now